Learn More
Apexbio Technology LLC Miltefosine, 50mg. Cas: 58066-85-6 MFCD: MFCD00133396. PI3K/Akt inhibitor

Supplier: Apexbio Technology LLC B137150
Miltefosine inhibits PI3K/Akt activity with ED50 of 17.2 uM and 8.1 uM in carcinoma cell lines A431 and HeLa, first oral drug for Visceral leishmaniasis, effective against both promastigotes and amastigotes. Phase 4. 58066-85-6. MFCD00133396
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.